Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$2.5200
+0.0900 ( +2.86% ) 169.8K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$2.5200
Previous close
$2.4300
Volume
169.8K
Market cap
$140.90M
Day range
$2.3400 - $2.5450
52 week range
$2.1550 - $7.6600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | May 09, 2024 |
| 10-q | Quarterly Reports | 64 | May 09, 2024 |
| def | Proxies and info statements | 4 | Apr 24, 2024 |
| ars | Annual reports | 1 | Apr 24, 2024 |
| 4 | Insider transactions | 1 | Apr 12, 2024 |
| 4 | Insider transactions | 1 | Apr 12, 2024 |
| 3 | Insider transactions | 2 | Apr 12, 2024 |
| 3 | Insider transactions | 2 | Apr 12, 2024 |
| pre | Proxies and info statements | 4 | Apr 12, 2024 |
| 8-k | 8K-related | 15 | Apr 11, 2024 |